Publications by authors named "Ben Carnley"
Article Synopsis
- Multiple myeloma is a terminal cancer that affects plasma cells, and a study reviewed patient survival in Western Australia over a decade.
- The research found no significant difference in survival rates between patients from metropolitan Perth and those from regional areas, despite fewer haematology services in rural locations.
- Patients diagnosed with R-ISS Stage 3 multiple myeloma had the lowest median survival time of 24 months in the study.
Background & Aims: Extrahepatic portal vein thrombosis and Budd-Chiari syndrome frequently result from multiple concurrent factors such as cirrhosis, intra-abdominal sepsis, procoagulant states, and underlying myeloproliferative disorders (MPDs). The JAK2 V617F mutation is a point mutation in the Janus kinase 2 (JAK2) tyrosine kinase that is variably present in MPDs. The incidence depends on the subclassification of the MPDs and the sensitivity of the assay used.
View Article and Find Full Text PDF